Katrine Bosley's guest appearances

Katrine Bosley

First Rounders

FierceBiotech Radio

Distillations | Science History Institute

The Long Run with Luke Timmerman

John Maraganore

Bassil Dahiyat

Ted Love

Alexis Borisy

Robert Langer

Daphne Zohar

George Yancopoulos

David Baltimore

George Church

Bonnie Anderson

Jim Geraghty

Feng Zhang

John Hawkins

Daniel Cohen

Colin Dickey

OwlTail

Katrine Bosley is former CEO of Editas Medicines and Avila Therapeutics. She discusses growing up in Ohio, her first job in biotech (as an administrative assistant) and why her five years at CRISPR company Editas felt more like 1,000. This episode is part of Nature Biotechnology's focus issue on translating the CRISPR technology. Hosted on Acast. See acast.com/privacy for more information.

Katrine Bosley is former CEO of Editas Medicines and Avila Therapeutics. She discusses growing up in Ohio, her first job in biotech (as an administrative assistant) and why her five years at CRISPR company Editas felt more like 1,000. This episode is part of Nature Biotechnology's focus issue on translating the CRISPR technology. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer nofollow" target="_blank">acast.com/privacy</a> for more information.

Over the next several weeks Distillations will be talking to people who have special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians. In this episode our producer Rigberto Hernandez talks with Katrine Bosley, who has worked in the biotech industry for more than 30 years. Until recently she was the CEO of Editas Medicine, a company that focuses on a gene-editing technology known as CRISPR. She’s now on the board of the Massachusetts Eye and Ear Hospital and is advising the facility on its quest to create a COVID-19 vaccine. She tells us how CRISPR can be used to make faster diagnostic tests and how the hospital in Boston is creating a vaccine using a gene therapy method.  “One of the things that’s important for all of us competing against this virus is to have a lot of technologically different strategies to try to make a vaccine.” Credits Hosts: Elisabeth Berry Drago, Alexis Pedrick  Senior Producer: Mariel Carr Producer: Rigoberto Hernandez Researcher: Jessica Wade Audio Engineer: Jonathan Pfeffer

Over the next several weeks Distillations will be talking to people who have special insight into the coronavirus crisis—biomedical researchers, physicians, public health experts, and historians. In this episode our producer Rigberto Hernandez talks with Katrine Bosley, who has worked in the biotech industry for more than 30 years. Until recently she was the CEO of Editas Medicine, a company that focuses on a gene-editing technology known as CRISPR. She’s now on the board of the Massachusetts Eye and Ear Hospital and is advising the facility on its quest to create a COVID-19 vaccine. She tells us how CRISPR can be used to make faster diagnostic tests and how the hospital in Boston is creating a vaccine using a gene therapy method.  “One of the things that’s important for all of us competing against this virus is to have a lot of technologically different strategies to try to make a vaccine.” Credits Hosts: <a href="https://www.sciencehistory.org/profile/elisabeth-berry-drago" rel="nofollow" target="_blank">Elisabeth Berry Drago</a>, <a href="https://www.sciencehistory.org/profile/alexis-j-pedrick" rel="nofollow" target="_blank">Alexis Pedrick </a> Senior Producer: <a href="https://www.sciencehistory.org/profile/mariel-carr" rel="nofollow" target="_blank">Mariel Carr</a> Producer: <a href="https://www.sciencehistory.org/profile/rigoberto-hernandez" rel="nofollow" target="_blank">Rigoberto Hernandez</a> Researcher: <a href="https://www.sciencehistory.org/profile/jessica-wade" rel="noopener nofollow" target="_blank">Jessica Wade</a> Audio Engineer: <a href="https://www.podbrain.org/" rel="noopener nofollow" target="_blank">Jonathan Pfeffer</a>

BONUS EPISODE: Pandemic Perspectives with Katrine Bosley

Ep. 2 of The Long Run With Luke Timmerman. Interview with Katrine Bosley, CEO of Editas Medicine.

Ep2: Katrine Bosley